Publicaciones (14) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. Correction to: SEOM clinical guidelines for endometrial cancer (2017) (Clinical and Translational Oncology, (2018), 20, 1, (29-37), 10.1007/s12094-017-1809-9)

    Clinical and Translational Oncology

  2. Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” (Annals of Oncology (2013) 24(S6) (vi24–vi32), (S0923753419315613), (10.1093/annonc/mdt333))

    Annals of Oncology

  3. Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2018), 20, 3, (274-285), 10.1007/s12094-017-1719-x)

    Clinical and Translational Oncology

  4. Erratum: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2017) 28 (iv72-iv83) DOI: 10.1093/annonc/mdx220)

    Annals of Oncology

  5. Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))

    Brachytherapy

  6. HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

    Annals of Oncology

  7. Immunodivergence in Metastatic Colorectal Cancer

    Cancer Cell

  8. Is there a role for HIPEC in ovarian cancer?

    Archives of Gynecology and Obstetrics

  9. Neoadjuvant immunotherapy in non-small cell lung cancer: The sooner the better?

    Translational Lung Cancer Research

  10. OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

    Obstetrical and Gynecological Survey

  11. Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia

  12. Reply to Francesco Massari and Vincenzo Di Nunno's Letter to the Editor re: Jose Luis Perez-Gracia, Yohann Loriot, Jonathan E. Rosenberg, et al. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens. Eur Urol 2018;73:462–8

    European Urology

  13. Rescuing Spanish Radiation Therapy: The Role of Leadership and Opportunity

    International Journal of Radiation Oncology Biology Physics

  14. Segmental Pneumonitis after Radioembolization

    Journal of Vascular and Interventional Radiology